Welcome to our dedicated page for PetVivo Holdings SEC filings (Ticker: PETV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on PetVivo Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into PetVivo Holdings's regulatory disclosures and financial reporting.
PetVivo Holdings, Inc. reported that Chief Executive Officer John Lai indirectly acquired 72,282 shares of restricted common stock. The shares were granted to a corporation he owns as compensation for his past performance. Following this award, that corporation’s indirect holdings increased to 2,240,492 common shares.
PetVivo Holdings, Inc. filed a current report to furnish an updated investor presentation under Regulation FD. Company representatives plan to use this presentation at investor conferences and other forums, and it is attached as Exhibit 99.1 and incorporated into the report by reference.
The investor presentation, dated March 2026, may also be used with investors, analysts and others and on the company’s website. The information is being furnished, not filed, so it is not subject to certain Exchange Act liabilities or automatically incorporated into Securities Act or Exchange Act registration statements.
PetVivo Holdings, Inc. reported another loss-making quarter for the period ended December 31, 2025, and disclosed substantial doubt about its ability to continue as a going concern. Quarterly revenue fell to $286,108 from $583,313 a year earlier, while the net loss available to common stockholders widened to $2,316,455. For the nine months, revenue was $886,892 versus $907,783, with a net loss of $7,788,904. Cash dropped to just $18,164, against an accumulated deficit of $98,987,394. The company shifted away from prior distributors, now relying heavily on Vedco for most sales, and added new licensing agreements for PrecisePRP and an AI platform that it expects to drive future revenue.
PetVivo Holdings, Inc. reported a change in its Board of Directors. On January 26, 2026, director Spencer Breithaupt resigned from the Board, effective that day. The company states his resignation was not due to any disagreement over operations, policies, or practices.
Following his departure, the Board reduced its size from seven to six directors and does not plan to immediately fill the vacancy, though it may add a seventh director in the future at its discretion. The Board expressed appreciation for Mr. Breithaupt’s leadership, guidance, and contributions during his service.
PetVivo Holdings, Inc. furnished a new investor presentation as part of a current report. Representatives plan to use this January 2026 presentation at investor conferences, in other forums, and on the company’s website.
The presentation is included as Exhibit 99.1 and is furnished under Regulation FD and Item 7.01, meaning it is not deemed filed for liability purposes under the Exchange Act and is not automatically incorporated into other securities filings unless specifically referenced. Management notes that the information is summary in nature and may be updated over time through future SEC reports, press releases, or other public disclosures.
PetVivo Holdings, Inc. investor updates ownership report. Individual shareholder Stanley Cruden reports beneficial ownership of 3,620,163 shares of PetVivo common stock, representing 9.37% of the class, as of the event date of 12/31/2025. He has sole power to vote and dispose of all these shares and reports no shared voting or dispositive power.
The certification states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of PetVivo Holdings, Inc., nor in connection with any control-related transaction, other than activities solely in connection with a nomination under the cited proxy rule.
A.L. Sarroff Fund, LLC, a 10% owner of PetVivo Holdings, Inc., reported a series of acquisitions of PetVivo common stock between October 18 and December 31, 2024. The transactions include numerous open-market purchases coded "P" at prices generally between $0.46 and $0.57 per share, as well as several entries coded "C" at $0.46 per share. After the final reported purchase of 16,001 shares at $0.57 on December 31, 2024, the fund held 7,740,579 shares of PetVivo common stock in direct ownership.
According to a footnote, Alan L. Sarroff is the Chief Executive Officer and Managing Member of A.L. Sarroff Fund, LLC and is deemed to beneficially own and have sole voting and dispositive power over the fund’s securities.
A.L. Sarroff Fund, LLC, a more than 10% owner of PetVivo Holdings, Inc. (PETV), filed a Form 4 detailing extensive insider activity in 2024. The fund reported multiple open-market purchases of PetVivo common stock between April 5 and October 15, 2024 at prices ranging from $0.40 to $1.06 per share, along with several warrant-related transactions, including exercises and new warrant purchases.
These transactions included warrant exercises that delivered shares, such as 770,767 common shares on September 26, 2024, and warrant acquisitions in February, April, May, June, and July 2024. Following the most recent trade on October 15, 2024, the fund directly beneficially owned 6,610,930 shares of PetVivo common stock, with additional common stock and warrants reported as indirectly owned, including securities held by the spouse of Alan L. Sarroff. Alan L. Sarroff is the chief executive officer and managing member of the fund and is deemed to beneficially own and have sole voting and dispositive power over its securities.
A.L. Sarroff Fund, LLC, a 10% owner of PetVivo Holdings, Inc., reported several equity transactions. On October 26, 2023, the fund acquired 164,340 shares of common stock at $0.73 per share, bringing its holdings to 1,748,251 common shares.
On December 15, 2023, the fund purchased an additional 111,112 common shares at $0.90 per share, increasing its position to 1,859,363 common shares. The same day, it bought 111,112 warrants with a $1.50 exercise price, each warrant exercisable for one share of common stock and expiring on December 15, 2026. A footnote states that Alan L. Sarroff, as Chief Executive Officer and Managing Member of the fund, is deemed to beneficially own and have sole voting and dispositive power over the fund’s securities.
PetVivo Holdings has a new major shareholder group disclosed in a Schedule 13D. A.L. Sarroff Fund, LLC, together with Alan and Eileen Sarroff, report beneficial ownership of 13,933,204 shares of common stock, representing approximately 36.1% of the company based on 33,580,630 shares outstanding as of November 14, 2025, and assuming the exercise of warrants to purchase 5,005,008 shares.
All of these shares are held with shared voting and dispositive power; none of the reporting persons has sole power over the shares. The position was built for investment purposes through open‑market purchases and private placements using personal funds. The reporting persons state they will continue to review their investment and may increase or decrease their holdings or economic exposure, including through derivatives such as swaps or options, but they do not currently outline specific corporate actions beyond standard possibilities referenced in Schedule 13D.